Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · IEX Real-Time Price · USD
43.50
+0.50 (1.16%)
May 3, 2024, 12:01 PM EDT - Market open
Xenon Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
3.28B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 9.43M | -9.00M | -48.83% |
Dec 31, 2021 | 18.44M | -13.73M | -42.68% |
Dec 31, 2020 | 32.17M | 25.34M | 371.02% |
Dec 31, 2019 | 6.83M | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 311.00K | -1.49M | -82.75% |
Dec 31, 2016 | 1.80M | -13.77M | -88.43% |
Dec 31, 2015 | 15.58M | -12.79M | -45.09% |
Dec 31, 2014 | 28.37M | 1.01M | 3.71% |
Dec 31, 2013 | 27.36M | 13.05M | 91.19% |
Dec 31, 2012 | 14.31M | 7.39M | 106.82% |
Dec 31, 2011 | 6.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.76B |
Fortrea Holdings | 3.11B |
Surgery Partners | 2.74B |
Evolent Health | 1.96B |
Progyny | 1.09B |
Sotera Health Company | 1.05B |
HUTCHMED (China) | 838.00M |
10x Genomics | 625.45M |
XENE News
- 20 hours ago - Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 17 days ago - Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - GlobeNewsWire
- 23 days ago - Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 4 weeks ago - Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update - GlobeNewsWire